VeriStat Webinars

  1. Rewriting The Code: Advances And Challenges In Pediatric Gene Therapy 7/28/2026

    This presentation examines pediatric gene therapy and the three platforms now driving clinical progress: AAV vectors, lentiviral vectors, and CRISPR-based gene editing.

  2. Days Instead Of Weeks: What It Actually Takes To Close The DBL-To-TLF Gap 6/25/2026

    The weeks after database lock often stall reporting. Here's how automated, deterministic TLF generation speeds up that timeline.

  3. Advancing Development Of New Oncology Therapies 4/4/2024

    Learn how the FDA's Project FrontRunner expedites cancer drug approval for early advanced metastatic cancer, emphasizing efficacy and safety in earlier clinical settings.

  4. Planning For A Successful Initial IND And Moving Beyond 10/10/2023

    Delve into the key challenges, effective strategies, and important considerations for analytical programs aimed at demonstrating comparability.

  5. Future Trends On European Regulations On Medicines 7/20/2023

    Gain insight from regulatory experts regarding unmet medical needs, accessibility and affordability, the competitive and innovative European pharma industry, enhancing resilience, and the EU’s global voice.

  6. EU Regulations Impacting Medical Device & Drug Combination Product Developments 7/20/2023

    Gain a better understanding of Regulation (EU) 2017/745, also known as the Medical Devices Regulation (MDR), by watching this presentation by regulatory experts.

  7. Single-Arm Studies For Use As A Registrational Study In Oncology 6/26/2023

    Listen in as industry experts discuss single-arm oncology registrational studies, success stories, and lessons learned.

  8. Decentralized Trial Solutions For Complex Clinical Trials: Webinar Replay 2/21/2023

    Most complex studies are considered challenging, but not impossible. Learn from a collective of experts on how to create successful decentralized clinical trials.

  9. Orphan Drug Designation: Considerations, Rewards, And Differences 11/11/2022

    The National Institutes of Health (NIH) estimates that 1 in 10 Americans are affected by a rare disease or condition. Explore global challenges and regulatory frameworks for rare diseases in this presentation.

  10. Pivoting To Remote Visits Mid-Study To Keep A Rare Disease Trial On-Track 8/22/2022

    Explore the challenges of designing and running an extraordinary complex natural history study - with both retrospective and prospective data – which then had to pivot to virtual patient visits mid-way through the data collection process.